{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000305","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.763458+00:00","generated_at":"2026-05-16T00:09:16.189570+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Anavex appoints Dr. Axel Paeger to Board of Directors effective Feb 23, 2026","bullets":["Dr. Paeger appointed to fill a vacancy on the board, effective February 23, 2026.","Board determined Paeger is independent under Exchange Act and Nasdaq rules.","Paeger is CEO of AMEOS Group, Europe's leading healthcare provider with 85 hospitals and 19,300 employees.","No arrangements or transactions requiring disclosure under Item 404(a) between Paeger and Anavex.","Paeger brings 30+ years of healthcare leadership; compensation consistent with other non-employee directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000305","json":"https://secwatch.observer/filing/0001731122-26-000305.json","markdown":"https://secwatch.observer/filing/0001731122-26-000305.md","text":"https://secwatch.observer/filing/0001731122-26-000305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000305/0001731122-26-000305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000305/e7371_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:09:16.189570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}